Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 8:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1033–1056 of 5,911 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: mRI Clear all

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 383 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Electronic Cigarette Related Lung Damage
Interventions: Hyperpolarized xenon 129, Cardiopulmonary Stress Test, Pulmonary Function Test, Chest CT; Drug · Diagnostic Test
Lead sponsor: Y. Michael Shim, MD; Other
Eligibility: 18 Years to 35 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2032
U.S. locations: 2
States / cities: Durham, North Carolina • Charlottesville, Virginia

Conditions: Anesthesia, Pain, Amnesia
Interventions: Sevoflurane, Peripheral Nerve Stimulation; Drug · Device
Lead sponsor: Keith M Vogt; Other
Eligibility: 18 Years to 59 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Acute Myocardial Infarction, Coronary Artery Disease, Myocardial Fibrosis, Gadolinium, Myocardial Edema
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 455 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: NAFLD, NASH - Nonalcoholic Steatohepatitis
Interventions: Magnetic resonance imaging (MRI), Magnetic resonance elastography (MRE), Prototype MRE soft flexible passive transducer paddle; Diagnostic Test · Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 1 Week to 40 Years
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Alcohol Use Disorder, Nicotine Use Disorder
Interventions: magnetic resonance imaging (MRI); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Breast Cancer
Interventions: Breath test; Diagnostic Test
Lead sponsor: SpotitEarly; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Totowa, New Jersey • Philadelphia, Pennsylvania

Conditions: Adult Solid Neoplasm, Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
Interventions: Computed Tomography, Fluorothymidine F-18, Laboratory Biomarker Analysis, Pharmacological Study, Positron Emission Tomography, Sunitinib Malate; Other · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Lesion in Body Region
Interventions: gadopiclenol, Gadobutrol 1 MMOLE/ML Intravenous Solution; Drug
Lead sponsor: Guerbet; Industry
Eligibility: 18 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 7
States / cities: Birmingham, Alabama • Farmington, Connecticut • Chicago, Illinois + 4 more

Conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 5 Years to 62 Years · Male only
Enrollment: 550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Gainesville, Florida • Portland, Oregon • Philadelphia, Pennsylvania

Conditions: Suicide, Depressive Disorder, Treatment-Resistant, Ketamine, Molecular Mechanisms of Pharmacological Action, Neurotransmitter Agents, Excitatory Amino Acid Agents, Physiological Effects of Drugs, Depressive Disorder, Major, Depressive Disorder, Depression, Mental Disorders, Mood Disorders, Behavioral Symptoms
Interventions: (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg), Placebo; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Type 2 Diabetes Mellitus, Diabetic Kidney Disease, Adolescent Obesity, Pre Diabetes, Kidney Hypoxia, Puberty
Interventions: Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, Dextran 40; Drug
Lead sponsor: Petter Bjornstad; Other
Eligibility: 8 Years to 14 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado • Seattle, Washington

Conditions: Major Depressive Disorder, Social Anxiety Disorder
Interventions: CBT, ST; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Brain Injury, Central Nervous System Degenerative Disorder, Central Nervous System Infectious Disorder, Central Nervous System Vascular Malformation, Hemorrhagic Cerebrovascular Accident, Ischemic Cerebrovascular Accident, Primary Brain Neoplasm, Brain Cancer, Brain Tumors
Interventions: Ferumoxytol, Tissue Analysis, Magnetic Resonance Imaging; Drug · Other · Procedure
Lead sponsor: Michael Iv; Other
Eligibility: 2 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Neoplasm, Stage I Pancreatic Cancer AJCC v6 and v7, Stage II Pancreatic Cancer AJCC v6 and v7
Interventions: 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Capecitabine, Chemotherapy, Computed Tomography, Erlotinib Hydrochloride, Fluorouracil, Gemcitabine Hydrochloride, Intensity-Modulated Radiation Therapy, Magnetic Resonance Imaging, Quality-of-Life Assessment, X-Ray Imaging; Radiation · Procedure · Drug + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 546 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2025
U.S. locations: 678
States / cities: Mobile, Alabama • Anchorage, Alaska • Auburn, California + 438 more

Conditions: Neurodegeneration With Brain Iron Accumulation (NBIA)
Interventions: Not listed
Lead sponsor: Susan J. Hayflick; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Obstructive Sleep Apnea of Adult
Interventions: Cryosa Procedure; Procedure
Lead sponsor: University of Pennsylvania; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Behavior, Health
Interventions: Radiotracer; Drug
Lead sponsor: Yale University; Other
Eligibility: 28 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Prostate Cancer
Interventions: Robot-assisted prostate biopsy; Device
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 35 Years to 75 Years · Male only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bipolar Depression, Suicidal Ideation
Interventions: NRX-101, Lurasidone HCl, Placebo; Drug
Lead sponsor: NeuroRx, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Amyloidosis, Hereditary, Amyloidosis Cardiac, Amyloidosis, Familial, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Transthyretin Gene Mutation
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 30 Years to 80 Years
Enrollment: 500 participants
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: New York, New York • Cleveland, Ohio • Dallas, Texas

Conditions: Children Requiring MRI
Interventions: axillary temperature before MRI and after the MRI; Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 6 Months to 8 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Osteochondritis Dissecans
Interventions: Platelet rich plasma (PRP); Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 10 Years to 17 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Eating Disorders
Interventions: MRI, Neuropsychological Testing; Other · Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 12 Years to 17 Years · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2021
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance

Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology

Sevoflurane's Effect on Neurocognition Study

Cardiac MRI for Patients Enrolled in INFUSE-AMI

Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE

Neurobiology of Alcohol and Nicotine Co-Addiction

Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)

Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

NBIAready: Online Collection of Natural History Patient-reported Outcome Measures

Imaging Predictors of Cryolysis Efficacy for Treatment of Obstructive Sleep Apnea

Novel in Vivo Synaptic Imaging in Experienced Meditators

Robot-Assisted MRI-Guided Prostate Biopsy

NRX101 Glx Biomarker Validation Study

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Pediatric Temperature Variation in the MRI Scanner Under General Anesthesia

Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee

An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa